Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
Pfeffer
J M
JM
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Fischer
T A
TA
Pfeffer
M A
MA
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure; D001920:Bradykinin / Q000502:physiology; D006332:Cardiomegaly / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003094:Collagen / Q000378:metabolism; D004730:Endothelium, Vascular / Q000473:pathology / Q000503:physiopathology; D006352:Heart Ventricles / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D012084:Renin-Angiotensin System / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D003094:Collagen; D007703:Peptidyl-Dipeptidase A; D001920:Bradykinin